Abstract
Purpose
To report 2 cases of paclitaxel-related maculopathy manifesting as cystoid macular edema (CME) with late petaloid hyperfluorescence on indocyanine green angiography (IA).
Cases
A 74-year-old man (patient 1) undergoing paclitaxel chemotherapy for gastric and metastatic liver cancer and a 69-year-old man (patient 2) receiving paclitaxel for hypopharyngeal cancer presented with anorthopia in both eyes. Spectral domain–optical coherence tomography (SD-OCT) revealed macular edema in both eyes of each patient. Fluorescein angiography showed weak petaloid pooling around the fovea in the late phase. IA revealed CME with petaloid hyperfluorescence that matched the region of macular edema detected by SD-OCT. The CME was attenuated in the right eye but not in the left eye of patient 1 at 2 weeks after discontinuation of paclitaxel treatment, whereas it was no longer apparent in either eye at 3 months. The CME was no longer detected in either eye of patient 2 at 3 months after discontinuation of paclitaxel.
Conclusion
These cases suggest that paclitaxel-induced CME may result from intraretinal accumulation of intracellular fluid and minimal impairment of the blood retinal barrier.
Similar content being viewed by others
References
Teitelbaum BA, Tresley DJ. Cystic maculopathy with normal capillary permeability secondary to docetaxel. Optom Vis Sci. 2003;80:277–9.
Telander DG, Sarraf D. Cystoid macular edema with docetaxel chemotherapy and the fluid retention syndrome. Semin Ophthalmol. 2007;22:151–3.
Baskin DE, Garg SJ. Abraxane-induced cystoid macular edema refractory to concomitant intravenous bevacizumab. Can J Ophthalmol. 2011;46:200–1.
Ito S, Okuda M. A case of cystic maculopathy during paclitaxel therapy. J Jpn Ophthalmol Soc. 2010;114:23–7.
Smith SV, Benz MS, Brown DM. Cystoid macular edema secondary to albumin-bound paclitaxel therapy. Arch Ophthalmol. 2008;156:1605–6.
Semb KA, Amandal S, Oilan P. Capillary protein leak syndrome appears to explain fluid retention in cancer patients who received docetaxel treatment. J Clin Oncol. 1998;16:3426–32.
Wolter JR. The histopathology of cystoid macular edema. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1981;216:85–101.
Joshi MM, Garreston BR. Paclitaxel maculopathy. Arch Ophthalmol. 2007;125:709–10.
Kuznetocova TI, Cech P, Herbort CP. The mystery of angiographically silent macular oedema due to taxanes. Int Ophthalmol. 2012;32:299–304.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
N. Nomi, None; M. Ota, None; M. Fukumura, None; Y. Nuno, None; M. Hatano, None; M. Wakuta, None; R. Yanai, None; K. Kimura, None.
About this article
Cite this article
Nomi, N., Ota, M., Fukumura, M. et al. Indocyanine green angiography findings of cystoid macular edema secondary to paclitaxel therapy. Jpn J Ophthalmol 62, 163–167 (2018). https://doi.org/10.1007/s10384-017-0552-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10384-017-0552-7